{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:18:07Z","timestamp":1783667887935,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959114"],"award-info":[{"award-number":["91959114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Technological Research Program of Tianjin Municipal Education Commission","award":["2019ZD025"],"award-info":[{"award-number":["2019ZD025"]}]},{"DOI":"10.13039\/501100019539","name":"Science Fund for Distinguished Young Scholars of Tianjin Municipality","doi-asserted-by":"publisher","award":["20JCJQJC00270"],"award-info":[{"award-number":["20JCJQJC00270"]}],"id":[{"id":"10.13039\/501100019539","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Technological Research Program of Tianjin Health Commission","award":["TJWJ2022XK015"],"award-info":[{"award-number":["TJWJ2022XK015"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-070C"],"award-info":[{"award-number":["TJYXZDXK-070C"]}]},{"name":"Talent Cultivation Project of Tianjin Institute of Urology","award":["MYSRC202301"],"award-info":[{"award-number":["MYSRC202301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80190-y","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T03:42:38Z","timestamp":1732419758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED ARTICLE: Association between low density lipoprotein cholesterol levels and prostate cancer risk in non-hypertensive middle-aged and older American men"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"80190_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. & Jemal, A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 77, 38\u201352 (2020).","journal-title":"Eur Urol."},{"key":"80190_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O. et al. 2022 update on prostate cancer epidemiology and risk factors\u2014A systematic review. Eur Urol. 84, 191\u2013206 (2023).","journal-title":"Eur Urol."},{"key":"80190_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia, G. et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 4, 877\u2013892 (2021).","journal-title":"Eur Urol Oncol."},{"key":"80190_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2188\/jea.JE20130006","volume":"23","author":"K Kotani","year":"2013","unstructured":"Kotani, K. et al. High-density lipoprotein and prostate cancer: An overview. J Epidemiol. 23, 313\u2013319 (2013).","journal-title":"J Epidemiol."},{"key":"80190_CR5","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/ijc.23715","volume":"123","author":"EA Platz","year":"2008","unstructured":"Platz, E. A., Clinton, S. K. & Giovannucci, E. Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer. 123, 1693\u20131698 (2008).","journal-title":"Int J Cancer."},{"key":"80190_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-14-1","volume":"14","author":"H Adachi","year":"2015","unstructured":"Adachi, H. et al. Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia. Lipids Health Dis. 14, 1 (2015).","journal-title":"Lipids Health Dis."},{"key":"80190_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 41, 111\u2013188 (2020).","journal-title":"Eur Heart J."},{"key":"80190_CR8","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 38, 2459\u20132472 (2017).","journal-title":"Eur Heart J."},{"key":"80190_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1158\/1055-9965.EPI-14-1329","volume":"24","author":"L YuPeng","year":"2015","unstructured":"YuPeng, L. et al. Cholesterol levels in blood and the risk of prostate cancer: A meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 24, 1086\u20131093 (2015).","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"80190_CR10","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/ijc.30013","volume":"138","author":"S Borgquist","year":"2016","unstructured":"Borgquist, S. et al. apolipoproteins, lipids and risk of cancer. Int J Cancer 138, 2648\u20132656 (2016).","journal-title":"Int J Cancer"},{"key":"80190_CR11","doi-asserted-by":"publisher","first-page":"24521","DOI":"10.1038\/srep24521","volume":"6","author":"P Tan","year":"2016","unstructured":"Tan, P. et al. LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies. Sci Rep. 6, 24521 (2016).","journal-title":"Sci Rep."},{"key":"80190_CR12","doi-asserted-by":"publisher","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","volume":"7","author":"D Bansal","year":"2012","unstructured":"Bansal, D., Undela, K., D\u2019Cruz, S. & Schifano, F. Statin use and risk of prostate cancer: A meta-analysis of observational studies. Gluud LL, editor. PLoS ONE. 7, e46691 (2012).","journal-title":"PLoS ONE."},{"key":"80190_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnci\/djr108","volume":"103","author":"WR Farwell","year":"2011","unstructured":"Farwell, W. R., D\u2019Avolio, L. W., Scranton, R. E., Lawler, E. V. & Gaziano, J. M. Statins and prostate cancer diagnosis and grade in a veterans population. JNCI J Natl Cancer Inst. 103, 885\u2013892 (2011).","journal-title":"JNCI J Natl Cancer Inst."},{"key":"80190_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/pcan.2011.30","volume":"14","author":"DEG Kok","year":"2011","unstructured":"Kok, D. E. G. et al. Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis. 14, 340\u2013345 (2011).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"80190_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/nu13072317","volume":"13","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Coffee consumption and prostate cancer risk: Results from national health and nutrition examination survey 1999\u20132010 and mendelian randomization analyses. Nutrients 13, 2317 (2021).","journal-title":"Nutrients"},{"key":"80190_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-021-00278-1","volume":"10","author":"NL Raftopulos","year":"2022","unstructured":"Raftopulos, N. L. et al. Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover. Cancer Metab. 10, 1 (2022).","journal-title":"Cancer Metab."},{"key":"80190_CR17","doi-asserted-by":"publisher","first-page":"e39445","DOI":"10.1371\/journal.pone.0039445","volume":"7","author":"TJ Murtola","year":"2012","unstructured":"Murtola, T. J. et al. The importance of LDL and cholesterol metabolism for prostate epithelial cell growth. PloS One 7, e39445 (2012).","journal-title":"PloS One"},{"key":"80190_CR18","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1002\/jcp.30229","volume":"236","author":"YY Jung","year":"2021","unstructured":"Jung, Y. Y. et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol. 236, 5253\u20135264 (2021).","journal-title":"J Cell Physiol."},{"key":"80190_CR19","doi-asserted-by":"publisher","first-page":"e1003859","DOI":"10.1371\/journal.pmed.1003859","volume":"19","author":"A Ioannidou","year":"2022","unstructured":"Ioannidou, A. et al. The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study. PLoS Med. 19, e1003859 (2022).","journal-title":"PLoS Med."},{"key":"80190_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n, J. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 41, 2313\u20132330 (2020).","journal-title":"Eur Heart J."},{"issue":"79","key":"80190_CR21","first-page":"2355","volume":"2022","author":"V Trimarco","year":"1979","unstructured":"Trimarco, V. et al. High HDL (High-Density Lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients. Hypertens Dallas Tex 2022(79), 2355 (1979).","journal-title":"Hypertens Dallas Tex"},{"key":"80190_CR22","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143\u2013421 (2002).","DOI":"10.1161\/circ.106.25.3143"},{"key":"80190_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1124\/jpet.123.001878","volume":"388","author":"V Trimarco","year":"2024","unstructured":"Trimarco, V. et al. Long-lasting control of LDL cholesterol induces a 40% reduction in the incidence of cardiovascular events: New insights from a 7-year study. J Pharmacol Exp Ther. 388, 742\u2013747 (2024).","journal-title":"J Pharmacol Exp Ther."},{"key":"80190_CR24","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.atherosclerosis.2023.06.971","volume":"378","author":"R Marfella","year":"2023","unstructured":"Marfella, R. et al. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Atherosclerosis 378, 117180 (2023).","journal-title":"Atherosclerosis"},{"key":"80190_CR25","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy, S. M. et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 73, e285-350 (2019).","journal-title":"J Am Coll Cardiol."},{"key":"80190_CR26","doi-asserted-by":"publisher","first-page":"895499","DOI":"10.3389\/fpubh.2022.895499","volume":"10","author":"S Chen","year":"2022","unstructured":"Chen, S. & Cheng, W. Relationship between lipid profiles and hypertension: A cross-sectional study of 62,957 Chinese adult males. Front Public Health 10, 895499 (2022).","journal-title":"Front Public Health"},{"key":"80190_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jacc.2007.02.073","volume":"50","author":"AA Alsheikh-Ali","year":"2007","unstructured":"Alsheikh-Ali, A. A., Maddukuri, P. V., Han, H. & Karas, R. H. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: Insights from large randomized statin trials. J Am Coll Cardiol. 50, 409\u2013418 (2007).","journal-title":"J Am Coll Cardiol."},{"key":"80190_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/jnci\/djr008","volume":"103","author":"M Benn","year":"2011","unstructured":"Benn, M., Tybj\u00e6rg-Hansen, A., Stender, S., Frikke-Schmidt, R. & Nordestgaard, B. G. Low-density lipoprotein cholesterol and the risk of cancer: A mendelian randomization study. JNCI J Natl Cancer Inst. 103, 508\u2013519 (2011).","journal-title":"JNCI J Natl Cancer Inst."},{"key":"80190_CR29","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(89)91790-X","volume":"334","author":"P Henriksson","year":"1989","unstructured":"Henriksson, P. et al. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. The Lancet 334, 1178\u20131180 (1989).","journal-title":"The Lancet"},{"key":"80190_CR30","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S0140-6736(85)92679-0","volume":"326","author":"S Vitols","year":"1985","unstructured":"Vitols, S., Bj\u00f6rkholm, M., Gahrton, G. & Peterson, C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: Evidence from studies in patients with leukaemia. The Lancet 326, 1150\u20131154 (1985).","journal-title":"The Lancet"},{"key":"80190_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.CIR.86.3.1046","volume":"86","author":"D Jacobs","year":"1992","unstructured":"Jacobs, D. et al. Report of the conference on low blood cholesterol: Mortality associations. Circulation 86, 1046\u20131060 (1992).","journal-title":"Circulation"},{"key":"80190_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaccao.2022.09.008","volume":"5","author":"H Klimis","year":"2023","unstructured":"Klimis, H. et al. The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis. JACC CardioOncology 5, 70\u201381 (2023).","journal-title":"JACC CardioOncology"}],"updated-by":[{"DOI":"10.1038\/s41598-026-58910-3","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80190-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:53:35Z","timestamp":1783666415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80190-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-58910-3","URL":"https:\/\/doi.org\/10.1038\/s41598-026-58910-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research ethics review board at the National Center for Health Statistics (NCHS) reviewed and approved studies involving human participants. Written informed consent was obtained from the patients\/participants for their participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors endorsed the definitive version of the manuscript for submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"29096"}}